Literature DB >> 2511239

Growth hormone response to thyrotropin releasing hormone and placebo in a group of insulin dependent diabetic patients.

U Valentini1, A Cimino, A Rotondi, L Rocca, R Pelizzari, A Giustina, C Marchetti, G Romanelli.   

Abstract

In order to evaluate if the assessment of the paradoxical GH responses to TRH in diabetic subjects could be altered by the presence of spontaneous fluctuations in plasma GH levels, we compared GH responses to TRH and to saline injection in 19 insulin-dependent diabetic patients. We observed significant increments (greater than 5 ng/ml) in plasma GH levels after TRH iv administration in 5 of 19 patients (26%); on the other hand, a significant increase was also observed in 6 patients (31%) after saline. We conclude that, at least in some diabetics, spontaneous GH pulses might be misinterpreted as paradoxical GH responses after a nonspecific stimulus administration. Moreover, the real existence of the paradoxical GH response to TRH has to be assessed using the following strict criteria: a sufficient magnitude in GH increment (greater than 5 ng/ml), the comparison of the kinetics of GH secretion after TRH and saline in the same patient, the presence of a significant GH rise above basal levels within the first 30 min after TRH injection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2511239     DOI: 10.1007/BF03350025

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  13 in total

1.  Effects of intravenous TRH on growth hormone and cortisol serum levels in children and adolescents with insulin dependent diabetes mellitus.

Authors:  M Vanelli; S Bernasconi; O Bolondi; C Mamì; E Pandullo; M Scaffidi; M F Siracusano; F De Luca
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

2.  [Growth hormone release in unstable diabetes: tests with saline, arginine, glucagon, and epinephrine (author's transl)].

Authors:  G M Cremer; G D Molnar; W F Taylor; J W Rosevear; E Ackerman
Journal:  Acta Diabetol Lat       Date:  1973

3.  Diurnal growth hormone and glucose abnormalities in unstable diabetics: studies of ambulatory-fed subjects during continuous blood glucose analysis.

Authors:  G D Molnar; W F Taylor; A Langworthy; V Fatourechi
Journal:  J Clin Endocrinol Metab       Date:  1972-05       Impact factor: 5.958

4.  Arginine induced growth hormone (hGH) response and paradoxical hGH secretion stimulated by TRH in diabetes mellitus.

Authors:  G Winkler; L Gerö; T Halmos; A Grósz; G Gefferth; P Varga; G Tamás
Journal:  Acta Diabetol Lat       Date:  1987 Apr-Jun

5.  Severe retinopathy and mild carbohydrate intolerance: possible role of insulin deficiency and elevated circulating growth hormone.

Authors:  A J Barnes; E M Kohner; D G Johnston; K G Alberti
Journal:  Lancet       Date:  1985-06-29       Impact factor: 79.321

6.  Interaction between somatostatin and TRH on growth hormone secretion in perifused human growth hormone tumor cells.

Authors:  M Le Dafniet; P Garnier; A M Brandi; D Bression; H Scherrer; J Racadot; F Peillon
Journal:  Horm Res       Date:  1985

7.  Diabetes, diabetic angiopathy, and growth hormone.

Authors:  K Lundbaek; N J Christensen; V A Jensen; K Johansen; T S Olsen; A P Hansen; H Orskov; R Osterby
Journal:  Lancet       Date:  1970-07-18       Impact factor: 79.321

8.  The growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics involves a cholinergic mechanism.

Authors:  P Chiodera; V Coiro; G Speroni; L Capretti; P Muzzetto; R Volpi; U Butturini
Journal:  J Clin Endocrinol Metab       Date:  1984-10       Impact factor: 5.958

9.  Nonspecific growth hormone responses to thyrotropin-releasing hormone in insulin-dependent diabetes: sex- and age-related pituitary responsiveness.

Authors:  G P Ceda; G Speroni; E Dall'Aglio; G Valenti; U Butturini
Journal:  J Clin Endocrinol Metab       Date:  1982-07       Impact factor: 5.958

10.  Integrated concentration of growth hormone in juvenile-onset diabetes.

Authors:  J T Hayford; M M Danney; J A Hendrix; R G Thompson
Journal:  Diabetes       Date:  1980-05       Impact factor: 9.461

View more
  1 in total

1.  Variability in the growth hormone response to growth hormone-releasing hormone alone or combined with pyridostigmine in type 1 diabetic patients.

Authors:  A Giustina; C Bodini; S Bossoni; U Valentini; W B Wehrenberg
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.